News
-
-
PRESS RELEASE
EQS-Adhoc: FamiCord AG acquires majority stake in Národní Centrum Pupečníkové Krve and Rodinná banka perinatálnych a mezenchymálnych buniek
FamiCord AG acquires majority stake in Národní Centrum Pupečníkové Krve and Rodinná banka perinatálnych a mezenchymálnych buniek from Primecell Advanced Therapy, expanding its stem cell bank services in Europe -
-
-
PRESS RELEASE
FamiCord AG starts 2025 financial year with accelerated growth and increases profitability at almost all earnings levels
FamiCord AG reports accelerated growth and enhanced profitability in the first quarter of 2025, with significant increases in group revenue and EBITDA. Confirmation of 2025 sales and earnings guidance -
-
-
PRESS RELEASE
FamiCord AG continues growth course in 2024 after strong year-end business and stabilizes business development in home market Germany
FamiCord AG reports 6.6% revenue growth to EUR 82.2 million in 2024, with EBITDA reaching EUR 8.8 million. Business development stabilizes in Germany. Company continues international expansion -
-